Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases
Emina Karahmet Sher, Adnan Ćosović, Amina Džidić-Krivić, et al.
Life Sciences (2023) Vol. 319, pp. 121531-121531
Open Access | Times Cited: 44
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 18
The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Salwa H Zekry, et al.
Neuroscience (2025)
Closed Access | Times Cited: 2
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 35
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 673-688
Closed Access | Times Cited: 28
Primary Hypothyroidism and Alzheimer’s Disease: A Tale of Two
Faisal Alanazi, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3405-3416
Open Access | Times Cited: 26
Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102119-102119
Closed Access | Times Cited: 26
Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears
Mubarak Alruwaili, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Neurochemical Research (2023) Vol. 48, Iss. 11, pp. 3255-3269
Open Access | Times Cited: 25
The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102075-102075
Closed Access | Times Cited: 23
Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 2
Open Access | Times Cited: 23
Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7092-7108
Open Access | Times Cited: 11
Role of brain renin–angiotensin system in depression: A new perspective
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 17
The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 7
COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage
Sumaiya Tasnim Maliha, Rabeya Fatemi, Yusha Araf
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 6
Neurological complications caused by SARS-CoV-2
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 6
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread
Aseel Awad Alsaidan, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 14
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
Lidan Hu, Wenmin Wang, Xiangjun Chen, et al.
Brain‐X (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Dantrolene and ryanodine receptors in COVID‐19: The daunting task and neglected warden
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 11
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 11
On the mechanism behind the enhanced solubility of glibenclamide in aqueous ionic liquid solution
Žyginta Murnikova, Vytautas Klimavičius, Francesca Mocci, et al.
Journal of Molecular Liquids (2025), pp. 127153-127153
Closed Access
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
Sharoen Yu Ming Lim, Basel Al Bishtawi, Willone Lim
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 221-240
Open Access | Times Cited: 10
Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 9
Oral Bemnifosbuvir (AT-527) Vs Placebo in Patients With mild-to-moderate COVID-19 in an Outpatient Setting (MORNINGSKY)
Arantxa Horga, Rebecca Saenz, Gürdal Yılmaz, et al.
Future Virology (2023) Vol. 18, Iss. 13, pp. 839-853
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top